Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
live lactobacillus capsule (vaginal)
- Development stage
- Unknown
- Lead developer
- Shuangqi Pharmaceutical
- Modality
- Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Vaginal
01
Overview
Ding Jun Sheng is a live biotherapeutic product consisting of live *Lactobacillus crispatus* (strain DM8909) formulated as a vaginal capsule. Developed and manufactured by Inner Mongolia Shuangqi Pharmaceutical, it is designed to restore the vaginal microecological balance. The lactobacilli in the capsule produce lactic acid and hydrogen peroxide, which lower the vaginal pH and inhibit the growth of anaerobic bacteria and other pathogens. It is clinically approved in China for the treatment of bacterial vaginosis and the restoration of vaginal flora after antibiotic or antifungal therapy. Beyond its approved indications, Ding Jun Sheng is currently being investigated in clinical trials, such as those sponsored by Peking University Shenzhen Hospital, for its potential to improve outcomes in women with recurrent implantation failure (RIF) by optimizing the reproductive tract microbiome prior to embryo transfer.
- Brand names
- Ding Jun Sheng定君生
- Other names
- Lactobacillus crispatus capsuleVaginal Lactobacillus Live CapsulesDing Jun Sheng live Lactobacillus capsuleDingjunsheng
Beyond the preview
Go deeper on live lactobacillus capsule (vaginal).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on live lactobacillus capsule (vaginal).